Chandra Bhagat Pharma Ltd

Chandra Bhagat Pharma Ltd

Chandra Bhagat Pharma Limited was incorporated as a private limited company with the name 'Chandra Bhagat Pharma Private Limited' at Mumbai on March 10 2003. Consequent upon the conversion of the Company from Private Limited Company to Public Limited Company the name of the Company was changed to 'Chandra Bhagat Pharma Limited' on March 20 2019.Inspirited by its founder Late Shree Chandravadan Bhagat's sense of personal mission the company is driven to fill the gap in pharma sector especially in critical lifesaving medicines in India. The Company was incorporated on March 10 2003 by Mr. Hemant Bhagat and Late. Shree Chandravadan Bhagat. On April 1 2003 the company acquired the going concern business of M/s. Chandra Bhagat Corporation ('partnership firm') along with all its assets and liabilities. Consequently the company issued equity shares to respective partners of M/s. Chandra Bhagat Corporation against the acquisition of going concern business along with all its assets and liabilities. The promoter Mr. Hemant Bhagat decided to continue on the footsteps of his father Late Shree Chandravadan Bhagat by focusing on marketing of life saving medicines like Antibiotics Antineoplastic Cardiovascular Hormones etc. and set up the company's marketing force in order to wider the product portfolio. Subsequently in the year 2004 the promoter Mr. Pranav Bhagat son of Mr. Hemant Bhagat being third generation also joined the business and decided to market the pharmaceuticals and special chemical products in domestic as well as in international market.The promoters have a combined experience of more than 41 years in the Pharmaceutical products Bulk drugs and vaccines. Driven by the passion for building an integrated pharmaceutical company backed by their more than two decades of experience the Promoters have been the pillars of the Company's growth since inception and have built a strong value system for the Company. With their enriching experience and progressive thinking the company aims to continue to grow in the pharmaceutical and bulk drugs in India and abroad.